139 related articles for article (PubMed ID: 22668882)
21. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
[TBL] [Abstract][Full Text] [Related]
22. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
[TBL] [Abstract][Full Text] [Related]
23. Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.
Furuzawa-Carballeda J; Lima G; Jakez-Ocampo J; Llorente L
Eur J Clin Invest; 2011 Oct; 41(10):1037-46. PubMed ID: 21366559
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine-pyrrole 2,3-dioxygenase might be a prognostic biomarker for patients with renal cell carcinoma.
Yuan F; Liu Y; Fu X; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):649-55. PubMed ID: 22886215
[TBL] [Abstract][Full Text] [Related]
26. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Ninomiya S; Hara T; Tsurumi H; Hoshi M; Kanemura N; Goto N; Kasahara S; Shimizu M; Ito H; Saito K; Hirose Y; Yamada T; Takahashi T; Seishima M; Takami T; Moriwaki H
Ann Hematol; 2011 Apr; 90(4):409-16. PubMed ID: 20938662
[TBL] [Abstract][Full Text] [Related]
28. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer.
Nishi M; Yoshikawa K; Higashijima J; Tokunaga T; Kashihara H; Takasu C; Ishikawa D; Wada Y; Shimada M
Anticancer Res; 2018 Jun; 38(6):3387-3392. PubMed ID: 29848687
[TBL] [Abstract][Full Text] [Related]
30. [Study of indoleamine 2,3-dioxygenase expression in patients of thyroid cancer].
Sakurai K; Fujisaki S; Nagashima S; Shibata M; Maeda T; Ueda Y; Hara Y; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1927-9. PubMed ID: 22202241
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer.
Iurchenko NP; Glushchenko NM; Buchynska LG
Exp Oncol; 2014 Dec; 36(4):262-6. PubMed ID: 25537221
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.
Kondratiev S; Sabo E; Yakirevich E; Lavie O; Resnick MB
Clin Cancer Res; 2004 Jul; 10(13):4450-6. PubMed ID: 15240536
[TBL] [Abstract][Full Text] [Related]
33. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
[TBL] [Abstract][Full Text] [Related]
34. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.
Hautz T; Brandacher G; Zelger B; Müller HG; Lee AW; Fuchs D; Margreiter R; Schneeberger S
Transplant Proc; 2009 Mar; 41(2):509-12. PubMed ID: 19328914
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
36. The role of tryptophan catabolism in acquisition and effector function of memory T cells.
Dai H; Dai Z
Curr Opin Organ Transplant; 2008 Feb; 13(1):31-5. PubMed ID: 18660704
[TBL] [Abstract][Full Text] [Related]
37. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
38. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
Jacquemier J; Bertucci F; Finetti P; Esterni B; Charafe-Jauffret E; Thibult ML; Houvenaeghel G; Van den Eynde B; Birnbaum D; Olive D; Xerri L
Int J Cancer; 2012 Jan; 130(1):96-104. PubMed ID: 21328335
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
40. Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma.
Ye J; Liu H; Hu Y; Li P; Zhang G; Li Y
Virchows Arch; 2013 Jan; 462(1):73-81. PubMed ID: 23179760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
